Canadian Drug Developer To Use OmniComm’s EDC

Published on: February 11, 2016

OmniComm’s TrialMaster EDC suite will be used for the collection of clinical data during a five year term in global Phase I to Phase III clinical studies.

OmniComm Systems, a leading provider of clinical data management technology, announced the signing of a five-year agreement with a Canadian pharmaceutical drug developer. OmniComm’s TrialMaster electronic data capture (EDC) suite will be used for the collection of clinical data during this five year term in numerous global trials spanning Phase I to Phase III clinical studies.

Read the full release.